美股异动 | Kardigan(KARD.US)登陆美股市场开盘涨超25%

智通财经06-19

智通财经APP获悉，周四，Kardigan(KARD.US)登陆美股市场，开盘股价涨超25%，报20.1美元。IPO价格为16美元。Kardigan是一家专注于心血管疾病创新疗法研发的临床阶段生物技术公司，致力于开发用于治疗心律失常及其他心脏疾病的新一代精准药物。公司核心产品管线聚焦于调节心脏电生理功能，通过靶向特定离子通道改善异常心律问题，目标是在提升疗效的同时降低传统抗心律失常药物带来的安全性...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2644708021?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-19 00:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644708021","market":"fut","top_or_hot":-1,"title":"美股异动 | Kardigan(KARD.US)登陆美股市场 开盘涨超25%","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，周四，Kardigan(KARD.US)登陆美股市场，开盘股价涨超25%，报20.1美元。IPO价格为16美元。Kardigan是一家专注于心血管疾病创新疗法研发的临床阶段生物技术公司，致力于开发用于治疗心律失常及其他心脏疾病的新一代精准药物。公司核心产品管线聚焦于调节心脏电生理功能，通过靶向特定离子通道改善异常心律问题，目标是在提升疗效的同时降低传统抗心律失常药物带来的安全性...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1456532.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股异动 | Kardigan(KARD.US)登陆美股市场 开盘涨超25%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股异动 | Kardigan(KARD.US)登陆美股市场 开盘涨超25%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-19 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1456532.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，周四，Kardigan(KARD.US)登陆美股市场，开盘股价涨超25%，报20.1美元。IPO价格为16美元。Kardigan是一家专注于心血管疾病创新疗法研发的临床阶段生物技术公司，致力于开发用于治疗心律失常及其他心脏疾病的新一代精准药物。公司核心产品管线聚焦于调节心脏电生理功能，通过靶向特定离子通道改善异常心律问题，目标是在提升疗效的同时降低传统抗心律失常药物带来的安全性...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1456532.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KARD","symbol_name":"Kardigan","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1456532.html","article_id":"2644708021","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2644708021","pubTimestamp":1781798400,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，周四，Kardigan(KARD.US)登陆美股市场，开盘股价涨超25%，报20.1美元。IPO价格为16美元。Kardigan是一家专注于心血管疾病创新疗法研发的临床阶段生物技术公司，致力于开发用于治疗心律失常及其他心脏疾病的新一代精准药物。公司核心产品管线聚焦于调节心脏电生理功能，通过靶向特定离子通道改善异常心律问题，目标是在提升疗效的同时降低传统抗心律失常药物带来的安全性风险。目前，公司多项候选药物仍处于临床开发阶段，尚未实现商业化收入。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"KARD":"Kardigan"},"translate_title":"U.S. stock changes | Kardigan (KARD.US) landed on the U.S. stock market and rose more than 25% at the opening","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KARD":1.5},"content_text":"智通财经APP获悉，周四，Kardigan(KARD.US)登陆美股市场，开盘股价涨超25%，报20.1美元。IPO价格为16美元。Kardigan是一家专注于心血管疾病创新疗法研发的临床阶段生物技术公司，致力于开发用于治疗心律失常及其他心脏疾病的新一代精准药物。公司核心产品管线聚焦于调节心脏电生理功能，通过靶向特定离子通道改善异常心律问题，目标是在提升疗效的同时降低传统抗心律失常药物带来的安全性风险。目前，公司多项候选药物仍处于临床开发阶段，尚未实现商业化收入。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644708021","isCrawlerRequest":true}

美股异动 | Kardigan(KARD.US)登陆美股市场 开盘涨超25%

精彩评论

美股异动 | Kardigan(KARD.US)登陆美股市场开盘涨超25%